Skip to main content
NCBI home page
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1978 May 1;147(5):1314–1333. doi: 10.1084/jem.147.5.1314

Anti-viral activity induced by culturing lymphocytes with tumor-derived or virus-transformed cells. Enhancement of human natural killer cell activity by interferon and antagonistic inhibition of susceptibility of target cells to lysis

PMCID: PMC2184280  PMID: 650156

Abstract

Interferon, induced in lymphocytes either with viruses or cell lines, increases severalfold the natural cytotoxicity of human lymphocytes on target cell lines. Cell separation experiments support the hypothesis that interferon enhances the activity of natural killer cells rather than generating a new population of effector cells. In mixed culture of lymphocytes and cell lines in which endogenous interferon is produced, interferon mediates an enhancement of cytotoxicity that represents up to 70-90% of the observed cytotoxicity. The effect of interferon on target cells is antagonistic to the effect on the lymphocytes: the susceptibility to cell-mediated lysis of various cells upon pretreatment with interferon is decreased and in some cases almost completely suppressed. Interferon renders target cells resistant to natural killer cells acting by an intracellular mechanism which requires RNA and protein synthesis. While normal fibroblasts are protected, virus-infected cells and most tumor cells usually are not protected by interferon. Interferon by stimulating very efficient nonspecific cytotoxic cells and by protecting at the same time normal cells from lysis, might render the natural killer cell system an inducible selective defense mechanism against tumor and virus-infected cells.

Full Text

The Full Text of this article is available as a PDF (1.2 MB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bakács T., Gergely P., Cornain S., Klein E. Characterization of human lymphocyte subpopulations for cytotoxicity against tumor-derived monolayer cultures. Int J Cancer. 1977 Apr 15;19(4):441–449. doi: 10.1002/ijc.2910190402. [DOI] [PubMed] [Google Scholar]
  2. Biddison W. E., Palmer J. C. Development of tumor cell resistance to syngeneic cell-mediated cytotoxicity during growth of ascitic mastocytoma P815Y. Proc Natl Acad Sci U S A. 1977 Jan;74(1):329–333. doi: 10.1073/pnas.74.1.329. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Billiau A., Heremans H., Allen P. T., De Maeyer-Guignard J., De Somer P. Trapping of oncornavirus particles at the surface of interferon-treated cells. Virology. 1976 Sep;73(2):537–542. doi: 10.1016/0042-6822(76)90416-5. [DOI] [PubMed] [Google Scholar]
  4. Bonavida B., Robins A., Saxon A. Lectin-dependent cellular cytotoxicity in man. Transplantation. 1977 Mar;23(3):261–270. doi: 10.1097/00007890-197703000-00009. [DOI] [PubMed] [Google Scholar]
  5. Braun W., Levy H. B. Interferon preparations as modifiers of immune responses. Proc Soc Exp Biol Med. 1972 Dec;141(3):769–773. doi: 10.3181/00379727-141-36868. [DOI] [PubMed] [Google Scholar]
  6. Dahl H., Degre M. Separation of antiviral activity of human interferon from cell growth inhibitory effect. Nature. 1975 Oct 30;257(5529):799–800. doi: 10.1038/257799a0. [DOI] [PubMed] [Google Scholar]
  7. Donahoe R. M., Huang K. Y. Interferon preparations enhance phagocytosis in vivo. Infect Immun. 1976 Apr;13(4):1250–1257. doi: 10.1128/iai.13.4.1250-1257.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Gisler R. H., Lindahl P., Gresser I. Effects of interferon on antibody synthesis in vitro. J Immunol. 1974 Aug;113(2):438–444. [PubMed] [Google Scholar]
  9. Golub S. H. In vitro sensitization of human lymphoid cells to antigens on cultured melanoma cells. I. Culture conditions resulting in augmented cell-mediated cytotoxicity. Cell Immunol. 1977 Feb;28(2):371–378. doi: 10.1016/0008-8749(77)90119-8. [DOI] [PubMed] [Google Scholar]
  10. Greenberg S. B., Criswell B. S., Couch R. B. Lymohocyte-mediated cytotoxicity against influenza virus-infected cells: an in vitro method. J Immunol. 1975 Aug;115(2):601–603. [PubMed] [Google Scholar]
  11. Herberman R. B., Nunn M. E., Holden H. T., Staal S., Djeu J. Y. Augmentation of natural cytotoxic reactivity of mouse lymphoid cells against syngeneic and allogeneic target cells. Int J Cancer. 1977 Apr 15;19(4):555–564. doi: 10.1002/ijc.2910190417. [DOI] [PubMed] [Google Scholar]
  12. Herberman R. B., Nunn M. E., Lavrin D. H. Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic acid allogeneic tumors. I. Distribution of reactivity and specificity. Int J Cancer. 1975 Aug 15;16(2):216–229. doi: 10.1002/ijc.2910160204. [DOI] [PubMed] [Google Scholar]
  13. Heron I., Berg K., Cantell K. Regulatory effect of interferon on T cells in vitro. J Immunol. 1976 Oct;117(4):1370–1373. [PubMed] [Google Scholar]
  14. Huang K. Y., Donahoe R. M., Gordon F. B., Dressler H. R. Enhancement of phagocytosis by interferon-containing preparations. Infect Immun. 1971 Nov;4(5):581–588. doi: 10.1128/iai.4.5.581-588.1971. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Härfast B., Andersson T., Perlmann P. Human lymphocyte cytotoxicity against mumps virus-infected target cells. Requirement for non-T cells. J Immunol. 1975 Jun;114(6):1820–1823. [PubMed] [Google Scholar]
  16. Johnson H. M., Baron S. The nature of the suppressive effect of interferon and interferon inducers on the in vitro immune response. Cell Immunol. 1976 Jul;25(1):106–115. doi: 10.1016/0008-8749(76)90100-3. [DOI] [PubMed] [Google Scholar]
  17. Jondal M., Pross H. Surface markers on human b and t lymphocytes. VI. Cytotoxicity against cell lines as a functional marker for lymphocyte subpopulations. Int J Cancer. 1975 Apr 15;15(4):596–605. doi: 10.1002/ijc.2910150409. [DOI] [PubMed] [Google Scholar]
  18. Julius M. H., Simpson E., Herzenberg L. A. A rapid method for the isolation of functional thymus-derived murine lymphocytes. Eur J Immunol. 1973 Oct;3(10):645–649. doi: 10.1002/eji.1830031011. [DOI] [PubMed] [Google Scholar]
  19. Kaplan M. E., Clark C. An improved rosetting assay for detection of human T lymphocytes. J Immunol Methods. 1974 Jul;5(2):131–135. doi: 10.1016/0022-1759(74)90003-9. [DOI] [PubMed] [Google Scholar]
  20. Kay H. D., Bonnard G. D., West W. H., Herberman R. B. A functional comparison of human Fc-receptor-bearing lymphocytes active in natural cytotoxicity and antibody-dependent cellular cytotoxicity. J Immunol. 1977 Jun;118(6):2058–2066. [PubMed] [Google Scholar]
  21. Kiessling R., Klein E., Wigzell H. "Natural" killer cells in the mouse. I. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Specificity and distribution according to genotype. Eur J Immunol. 1975 Feb;5(2):112–117. doi: 10.1002/eji.1830050208. [DOI] [PubMed] [Google Scholar]
  22. Kreth W. H., Käckell M. Y., ter Meulen V. Demonstration of in vitro lymphocyte-mediated cytotoxicity against measles virus in SSPE. J Immunol. 1975 Mar;114(3):1042–1046. [PubMed] [Google Scholar]
  23. Lazarowitz S. G., Compans R. W., Choppin P. W. Influenza virus structural and nonstructural proteins in infected cells and their plasma membranes. Virology. 1971 Dec;46(3):830–843. doi: 10.1016/0042-6822(71)90084-5. [DOI] [PubMed] [Google Scholar]
  24. Lindahl-Magnusson P., Leary P., Gresser I. Interferon inhibits DNA synthesis induced in mouse lymphocyte suspensions by phytohaemagglutinin or by allogeneic cells. Nat New Biol. 1972 May 24;237(73):120–121. doi: 10.1038/newbio237120a0. [DOI] [PubMed] [Google Scholar]
  25. Lindahl P., Leary P., Gresser I. Enhancement by interferon of the expression of surface antigens on murine leukemia L 1210 cells. Proc Natl Acad Sci U S A. 1973 Oct;70(10):2785–2788. doi: 10.1073/pnas.70.10.2785. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Lindahl P., Leary P., Gresser I. Enhancement by interferon of the specific cytotoxicity of sensitized lymphocytes. Proc Natl Acad Sci U S A. 1972 Mar;69(3):721–725. doi: 10.1073/pnas.69.3.721. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Mahowald M. L., Handwerger B. S., Capertone E. M., Jr, Douglas S. D. A comparative study of procedures for sheep erythrocyte-human-T-lymphocyte rosette formation. J Immunol Methods. 1977;15(3):239–245. doi: 10.1016/0022-1759(77)90061-8. [DOI] [PubMed] [Google Scholar]
  28. Moller-Larsen A., Heron I., Haahr S. Cell-mediated cytotoxicity to herpes-infected cells in humans: dependence on antibodies. Infect Immun. 1977 Apr;16(1):43–47. doi: 10.1128/iai.16.1.43-47.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Moss B. Inhibition of HeLa cell protein synthesis by the vaccinia virion. J Virol. 1968 Oct;2(10):1028–1037. doi: 10.1128/jvi.2.10.1028-1037.1968. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. PHILLIPS H. J., TERRYBERRY J. E. Counting actively metabolizing tissue cultured cells. Exp Cell Res. 1957 Oct;13(2):341–347. doi: 10.1016/0014-4827(57)90013-7. [DOI] [PubMed] [Google Scholar]
  31. Pape G. R., Troye M., Perlmann P. Characterization of cytolytic effector cells in peripheral blood of healthy individuals and cancer patients. II. Cytotoxicity to allogeneic or autochthonous tumor cells in tissue culture. J Immunol. 1977 Jun;118(6):1925–1930. [PubMed] [Google Scholar]
  32. Peter H. H., Eife R. F., Kalden J. R. Spontaneous cytotoxicity (SCMC) of normal human lymphocytes against a human melanoma cell line: a phenomenon due to a lymphotoxin-like mediator. J Immunol. 1976 Feb;116(2):342–348. [PubMed] [Google Scholar]
  33. Rager-Zisman B., Grose C., Bloom B. R. Mechanism of selective nonspecific cell-mediated cytotoxicity of virus-infected cells. Nature. 1976 Mar 25;260(5549):369–370. doi: 10.1038/260369a0. [DOI] [PubMed] [Google Scholar]
  34. Santoli D., Trinchieri G., Zmijewski C. M., Koprowski H. HLA-related control of spontaneous and antibody-dependent cell-mediated cytotoxic activity in humans. J Immunol. 1976 Sep;117(3):765–770. [PubMed] [Google Scholar]
  35. Sharma B. S. In vitro lymphocyte immunization to cultured human tumor cells: parameters for generation of cytotoxic lymphocytes. J Natl Cancer Inst. 1976 Oct;57(4):743–748. doi: 10.1093/jnci/57.4.743. [DOI] [PubMed] [Google Scholar]
  36. Sharma B., Tubergen D. G., Minden P., Brunda M. J. In vitro immunisation against human tumour cells with bacterial extracts. Nature. 1977 Jun 30;267(5614):845–847. doi: 10.1038/267845a0. [DOI] [PubMed] [Google Scholar]
  37. Takasugi M., Mickey M. R., Terasaki P. I. Reactivity of lymphocytes from normal persons on cultured tumor cells. Cancer Res. 1973 Nov;33(11):2898–2902. [PubMed] [Google Scholar]
  38. Tan Y. H., Tischfield J., Ruddle F. H. The linkage of genes for the human interferon-induced antiviral protein and indophenol oxidase-B traits to chromosome G-21. J Exp Med. 1973 Feb 1;137(2):317–330. doi: 10.1084/jem.137.2.317. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Trinchieri G., Aden D. P., Knowles B. B. Cell-mediated cytotoxicity to SV40-specific tumour-associated antigens. Nature. 1976 May 27;261(5558):312–314. doi: 10.1038/261312a0. [DOI] [PubMed] [Google Scholar]
  40. Trinchieri G., De Marchi M. Antibody-dependent cell-mediated cytotoxicity in humans. III. Effect of protease inhibitors and substrates. J Immunol. 1976 Apr;116(4):885–891. [PubMed] [Google Scholar]
  41. Trinchieri G., De Marchi M., Mayr W., Savi M., Ceppellini R. Lymphocyte antibody lymphocytolytic interaction (LALI) with special emphasis on HL-A. Transplant Proc. 1973 Dec;5(4):1631–1649. [PubMed] [Google Scholar]
  42. Trinchieri G., Santoli D., Dee R. R., Knowles B. B. Anti-viral activity induced by culturing lymphocytes with tumor-derived or virus-transformed cells. Identification of the anti-viral activity as interferon and characterization of the human effector lymphocyte subpopulation. J Exp Med. 1978 May 1;147(5):1299–1313. doi: 10.1084/jem.147.5.1299. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Trinchieri G., Santoli D., Zmijewski C. M., Koprowski H. Functional correlation between antibody-dependent and spontaneous cytotoxic activity of human lymphocytes and possibility of an HLA-related control. Transplant Proc. 1977 Mar;9(1):881–884. [PubMed] [Google Scholar]
  44. Weiner M. S., Bianco C., Nussenzweig V. Enhanced binding of neuraminidase-treated sheep erythrocytes to human T lymphocytes. Blood. 1973 Dec;42(6):939–946. [PubMed] [Google Scholar]
  45. Wolfe S. A., Tracey D. E., Henney C. S. Introduction of "natural" killer' cells by BCG. Nature. 1976 Aug 12;262(5569):584–586. doi: 10.1038/262584a0. [DOI] [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES